ThromboVision is a medical devices company that has developed a technological platform to determine an individual’s susceptibility to thrombosis, an adverse blood clot formation that can cause blockage of blood vessels leading to heart attack or stroke. The company uses a proprietary light scattering technology to measure an individual’s platelet levels, the cells in the body that lead to the formation of blood clots, thereby determining the patient’s risk factor for thrombosis. The company’s apparatus is simple and inexpensive to use, making it beneficial in both doctor’s office and hospital settings. Adverse blood clots in the systemic circulation can cause blood vessel blockage leading to a heart attack or stroke, yet diagnostics that can determine a patient’s susceptibility to blood clotting is lacking.